Stealth CEO Reenie McCarthy said the FDA made an informed, science-based decision to approve Forzinity, recognizing both the ...
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
The FDA declined to consider elamipretide for full approval in 2021 and rejected the company's application in May of 2025 ...
Medpage Today on MSN
FDA Approves IV Antibiotic for Complicated UTIs
The FDA approved an intravenous (IV) formulation of fosfomycin (Contepo) to treat adults with complicated urinary tract ...
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
The White House argued lethal military strikes against alleged drug trafficking boats in the Caribbean and Eastern Pacific do ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
The Office of Secretary of Defense Pete Hegseth has disemminated a broad list of topics that DoD personnel are now required ...
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
Ironwood Pharmaceuticals (IRWD) stock gains as the FDA approves a label expansion for the company's AbbVie (ABBV)-partnered ...
Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...
The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback